Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Servier in the Drug Discovery & Development Pharma 50

Servier

Rank: 40

2021 Rank: 35

Paris, France
servier.com

2021 Revenues ($USD) : $5,575,500,000
2021 Revenues (foreign currencies) : €4,725,000,000
2021 Number of Employees : 21,800
Fiscal Year End : 9/30/2021
Leader : President Olivier Laureau

Governed by a non-profit foundation, Servier is headquartered in Suresnes, France, a suburb of Paris. Servier is the largest independent pharma company in France and trails only Sanofi in terms of overall size in the country. Specializing in developing drugs for oncology, cardiometabolism, neuroscience and immuno-inflammation indications, Servier distributes its products in more than 150 countries. The company was founded by the French physician and entrepreneur Jacques Servier. —BB

Servier

[Servier Paris-Saclay Research Institute. Image courtesy of Servier.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE